Recent Patent Cases and Generic Delays: 2023-2025 Examples
Despite FDA approval, many generic drugs face years of delays due to patent litigation. Between 2023 and 2025, patent thicketing, 30-month stays, and complex drug types pushed average launch delays to 3.2 years, costing patients billions.
8 Jan 2026